Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema

NCT01492400 PHASE2 COMPLETED Results posted

This study will compare the safety and efficacy of the 700 ug dexamethasone intravitreal implant with ranibizumab 0.5 mg intravitreal injections in patients with diabetic macular edema (DME).

Details

Lead sponsor	Allergan
Phase	PHASE2
Status	COMPLETED
Enrolment	363
Start date	Fri Mar 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Feb 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Macular Edema

Interventions

• dexamethasone Intravitreal Implant
• ranibizumab

Countries

Denmark, France, Italy, Netherlands, South Africa, Belgium, United Kingdom, Germany, Israel, Portugal, United States, Spain